Ascentage Pharma Group International 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Ascentage Pharma Group International filed its annual report on Form 20-F for the fiscal year ended December 31, 2025, detailing its financial performance, clinical pipeline, and strategic outlook.
NASDAQ
Ascentage Pharma Group International's 20-F filing details the company's financial performance for the year ended December 31, 2024, along with key business and operational updates.